Abstract:Objectives To compare the levels of lncRNA1 and lncRNA2 expression in the peripheral blood of patients with active tuberculosis and patients with a latent tuberculosis infection to levels in healthy controls before and after stimulation with Mtb-specific antigens and to explore the use of levels of mRNA expression as possible biomarkers for the diagnosis of TB.Methods Before and after stimulation with Mtb-specific antigens,the peripheral blood of patients with active pulmonary tuberculosis (TB),a latent tuberculosis infection (LTBI),and healthy controls was collected and RNA was extracted.The expression of lncRNA1 and lncRNA2 mRNA was detected with real-time quantitative PCR.ELISA was used to detect IFN-γ and IL-2 levels in plasma.Results Before stimulation with Mtb-specific antigens,the relative level of lncRNA1 expression in patients with TB decreased 32 ％ and that in patients with an LTBI decreased 64％ in com parison to healthy controls.The relative level of lncRNA2 expression in patients with TB was 6.10 times that in healthy controls.After stimulation with Mtb-specific antigens,the relative level of lncRNA1 expression in patients with TB decreased 33％ and that in patients with an LTBI decreased 77％ in comparison to healthy controls.The relative level of lncRNA2 expression in patients with TB decreased 84％ in comparison to that in healthy controls.After stimulation with Mtb-specific antigens,the relative level of lncRNA1 expression in healthy controls was 1.80 times that in patients not simulated with those antigens and the relative level of lncRNA1 expression in TB was 2.80 times that in patients not sim ulated with those antigens.The relative level of lncRNA2 expression in healthy controls was 3.50 times that in patients not simulated with antigens and the relative level of lncRNA2 expression in LTBI was 1.86 times that in patients not simulated with antigens (P＜0.05).Receiver operating characteristic (ROC) curve analysis of lncRNA1 in healthy controls and patients with a LTBI indicated that that the area under the curve (AUC) was 0.700.ROC curve analysis of lncRNA1 in patients with TB and patients with an LTBI indicated that the AUC was 0.752.ROC curve analysis of lncRNA1 in healthy controls and patients with TB indicated that that the AUC was 0.400.ROC curve analysis of lncRNA2 in healthy controls and patients with a LTBI indicated that that the area under the curve (AUC) was 0.702.ROC curve analysis of lncRNA2 in patients with TB and patients with an LTBI indicated that the AUC was 0.465.ROC curve analysis of lncRNA2 in healthy controls and patients with TB indicated that that the AUC was 0.762.Levels of IFN-γ and IL-2 in patients with TB were higher before stimulation with Mtb-specific antigens than those in healthy controls (P＜0.05).After stimulation with Mtb-specific antigens,levels of IFN-γwere compared in patients with TB,patients with an LTBI,and healthy controls.Levels of IFN-γ were higher in patients with an LTBI and in patients with TB (P＜0.05).Stimulation with Mtb-specific antigens induced significantly higher levels of IFN-γ and IL-2 expression in all three groups (P＜0.05).Conclusion Significant differences in levels of lncRNA1 and lncRNA2 expression were noted in peripheral blood from patients with TB,patients with an LTBI,and healthy controls before and after stimulation with Mtb-specific antigens.Levels of IFN-γ in plasma were higher in patients with active pulmonary TB and an LTBI.lncRNA1 and lncRNA2 may be used as potential biomarkers for the diagnosis of TB.

Diagnostic value of lncRNAs LINC00152 and LARS2-AS1 and their regulatory roles in macrophage immune response in tuberculosis

Long Non-Coding RNA Expression in PBMCs of Patients with Active Pulmonary Tuberculosis

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Profiling the Mrna and Mirna in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis

Long Non-coding RNAs in Tuberculosis: From Immunity to Biomarkers

Clinical Significance of Lnc-Ac145676.2.1-6 and Lnc-Tgs1-1 and Their Variants in Western Chinese Tuberculosis Patients.

Differences in expression of lncRNA in peripheral blood from patients with tuberculosis

Up-regulated long noncoding RNA AC007128.1 and its genetic polymorphisms associated with Tuberculosis susceptibility

Long Non-Coding RNAs ENST00000429730.1 and MSTRG.93125.4 Are Associated with Metabolic Activity in Tuberculosis Lesions of Sputum-Negative Tuberculosis Patients

Expression and Clinical Significances of Lncrna MALAT 1 in Mycobacterium Tuberculosis Infection

MicroRNAs As Immune Regulators and Biomarkers in Tuberculosis

Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis

Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq

RETRACTED: LncRNA NEAT1 participates in inflammatory response in macrophages infected by mycobacterium tuberculosis through targeted regulation of miR-377–3p

The hsa_circ_0002371/hsa-miR-502-5p/ATG16L1 axis modulates the survival of intracellular Mycobacterium tuberculosis and autophagy in macrophages

Clinical Value of Serum Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in the Diagnosis of Pulmonary Tuberculosis

Identification of apoptosis-related gene signatures as potential biomarkers for differentiating active from latent tuberculosis via bioinformatics analysis

Lymphocyte-Related Immunological Indicators for Stratifying <i>Mycobacterium tuberculosis</i> Infection

Differential expression of long non-coding RNAs in patients with tuberculosis infection.

Neutrophil lncRNA ZNF100-6:2 is a potential diagnostic marker for active pulmonary tuberculosis

Long Non-Coding RNA Expression Profiling of Macrophage Line RAW264.7 Infected by Mycobacterium Tuberculosis